New Clinical and Real-World Data Support Use of DARZALEX® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with...

Related Keywords

United States ,Virginia ,Chicago ,Illinois ,American ,Bortezomib Melphalan ,Velcade Melphalan ,Jacob Laubach ,Velcade Bortezomib Melphalan ,Jessica Moore ,Imran Khan ,Satu Glawe ,Amgen ,Janssen Biotech Inc ,American Society Of Hematology Annual Meeting ,Jerome Lipper Multiple Myeloma Center ,Janssen Research Development ,Janssen Pharmaceutical Companies ,Janssen Pharmaceutical Companies Of Johnson ,American Society Of Hematology ,Janssen Scientific Affairs ,National Library Of Medicine ,Dana Farber Cancer Institute ,European Myeloma Network ,None Of The Janssen Pharmaceutical Companies ,Drug Administration ,Flatiron Health ,Exchange Commission ,Companies Of Johnson ,Johnson ,American Society ,Clinical Director ,Medical Affairs ,New England Journal ,Real World Data ,Janssen Biotech ,Interference With Serological ,With Determination ,Pharmaceutical Companies ,Infectious Diseases ,Janssen Research ,Private Securities Litigation Reform Act ,Annual Report ,Note Regarding Forward Looking ,Quarterly Report ,Plus Lenalidomide ,Updated Analysis ,Hematology Annual ,Online Use ,Dexamethasone Confers Survival Benefit Compared ,Second Line Use ,Daratumumab Based Regimens ,Transplant Ineligible Patients ,Multiple Myeloma ,Different Clinical ,Prescribing Information ,Annual Meeting ,Clinical Oncology ,Study Comparing Daratumumab ,Dexamethasone With Lenalidomide ,Refractory Multiple ,National Library ,Participants With Relapsed ,Evaluate Daratumumab ,Velcade Melphalan Prednisone ,Comparing Daratumumab ,Participants With Previously Untreated Multiple ,Combination With ,High Dose Therapy ,Asia Pacific Region ,European Myeloma ,Compare Progression Free Survival Btw ,Patients With Relapsed ,The Janssen Pharmaceutical Companies Of Johnson Amp ,